Staar Surgical pointed to about a 15% sales growth CAGR scenario through FY26 in slides for its investor day meeting.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on STAA:
- Staar Surgical to replace Urstadt Biddle in S&P 600 at open on 8/22
- Dolby to replace Staar Surgical in S&P 400 at open on 8/22
- Staar Surgical price target lowered to $45 from $50 at Stifel
- Staar Surgical price target lowered to $57 from $71 at Stephens
- Staar Surgical price target lowered to $50 from $65 at Piper Sandler